When patients and their oncologists hold fundamentally different assumptions about the same therapy, clinical encounters break down — and that communication gap may have measurable consequences for health outcomes. This dual-survey study illuminates exactly that fault line in oncology cannabis discussions, with implications for how cannabis conversations are structured in cancer care settings.
Researchers conducted parallel surveys of 395 cancer survivors and 62 cancer care providers, probing attitudes, perceived benefits and risks, and — critically — readiness to discuss cannabis. The most striking divergence emerged around risk awareness: only 8.4% of survivors acknowledged cannabis risks, compared with 25% of providers, a highly significant gap. Paradoxically, survivors were far more comfortable initiating cannabis conversations (68.5%) than providers were (46.7%). Among survivors who reported current cannabis use versus those who had never used, a complex profile emerged: cannabis users reported higher social well-being but lower physical and emotional well-being, greater healthcare system mistrust, reduced healthcare utilization, and elevated rates of anxiety, depression, smoking, and vaping — though chronic pain and alcohol use did not differ significantly between groups.
This study contributes an important counternarrative to the prevailing assumption that providers drive communication barriers around cannabis. Here, providers appear more hesitant to engage despite patients being open to the conversation — a reversal of the classic dynamic. That said, several limitations temper interpretation: the provider sample (n=62) is notably small and likely non-representative of the broader oncology workforce, the cross-sectional design prevents causal inference, and selection bias is plausible since survey participants may skew toward cannabis-engaged individuals. The clustering of anxiety, depression, and tobacco use among cannabis-using survivors warrants careful attention — whether cannabis use precedes or follows these conditions remains unanswerable here. Overall, this is a useful descriptive snapshot rather than a paradigm-shifting finding, with its greatest value lying in quantifying the provider-hesitancy paradox that clinicians and educators can act on.